The aim of this study was to identify active ingredients present in counterfeit drugs and pharmaceutical preparations seized from the black market among bodybuilders. Preparations in closed or sealed packaging with different batch numbers (n = 74) and two preparations without labels were analyzed. Methods: The identification scheme was based on reversed-phase liquid chromatography with a photodiode array UV detector and gas chromatography-mass spectrometry. Methanolic sample extracts of tablets, capsules, oral jellies and water-based injectables were chromatographed on a ChromSpher 5 C18 column using a gradient program of triehylammonium phosphate and acetonitrile as mobile phases and were monitored at the wavelengths 220 nm and 254 nm. Oil-based injectables (n = 41) were extracted with hexane and methanol. The methanolic sample extracts and diluted supernatant layers were injected into an Agilent 6890 N gas chromatograph with a fused silica CPSIL 8CB low-bleed capillary column and Agilent 5973 inert mass selective detector operated in full-scan mode. The identified compound(s) were checked against the active ingredient(s) declared on the label. Conclusion: Packaging from counterfeits produced in underground labs cannot be visually distinguished from packaging originating from legitimate pharmaceutical companies. Out of 74 labeled products, the content of 25 (33.8%) did not match the label. Anabolic androgenic steroids are commonly found on the black market among bodybuilders, predominately esterified in oil-based injectables. Out of 40 steroidal oily solutions, the active ingredients of 21 (52.5%) did not match the label: one preparation did not contain an active compound, 20 contained other or more active ingredients. The additional compounds were often present in smaller quantities, which could be indicative of contamination. Active ingredients such as methandrostenolone, sildenafil, tamoxifen, quinine, clomiphene, dehydroepiandrosterone, anastrazole, clenbuterol, stanozolol, oxandrolone, liothyronine, finasteride and melatonin were identified in tablets, oral jellies and water-based injectables.
Introduction
Bodybuilders purchase preparations to enhance muscle size and strength and to alleviate adverse effects associated with steroid use or to mask steroid abuse. Counterfeit products produced in so-called "underground labs" are available on the black market and are offered on the internet as legitimate pharmaceutical preparations. Besides the health issues associated with the use of androgenic anabolic steroids and drugs obtained without the mandatory subscription, unexpected side effects can occur when preparations do not or do not only contain the claimed active compounds.
The identification of active ingredients in confiscated illegally distributed anabolic steroid products and/or black market drugs was previously reported by Walters et al. (1990) , Musshoff et al. (1997) , Ritsch et al. (2000) , Thevis et al. (2008) [1] [2] [3] [4] and Kohler et al. (2009) [5] .
This paper reports the analysis of 76 products confiscated from the black market among bodybuilders. Identification of active compounds in sample extracts was based on reversedphase liquid chromatography with a photodiode array UV detector (HPLC/PDA) and quadrupole gas chromatographymass spectrometry (GC/MS).
Materials and methods

Samples
Preparations confiscated from different individuals suspected to use or to be involved in the black market of counterfeits and pharmaceuticals among bodybuilders were submitted to the laboratory for identification of active compounds. Tablets (n = 26), capsules (n = 3), oral jellies (n = 4), aqueous solutions for intramuscular injection (n = 2) and oily solutions for intramuscular injection (n = 41) were analyzed. Preparations in closed or sealed packaging with different batch numbers (n = 74) and two preparations without labels were included in the study.
Sample extraction
Capsules, tablets, oral jellies and water-based injectables
To a finely-ground tablet, gel or water-based injectable from one dosage form, methanol was added. The concentration of the active ingredients on the labels was used as a guideline to obtain theoretical concentrations of 1 mg/mL. The suspensions and solutions were vortex-mixed and sonicated for 10 min. After centrifugation, 50 μL of the supernant layer was transferred to an auto-sampler vial containing the external standard solution, 20 μg/mL diphenylamine in the initial mobile phase. After homogenization, the sample was injected into the HPLC/PDA. For the GC/MS analysis, the methanolic supernant layer was diluted (1:1) in methanol (containing 100 μg/mL diphenylamine) before injection.
Oil-based injectables
Oil-based injectables were extracted with methanol and hexane [6] .
Liquid chromatography
The HPLC/PDA analysis was performed using a Varian Prostar solvent delivery module in combination with a Varian Prostar 410 auto-sampler and Varian Prostar photodiode array detector. Data acquisition and analysis were performed with the Varian Star and Polyview software. A Lichrospher r 100 RP-18 (5 μm) was used as a saturation column. The separation of compounds was performed in gradient mode with the use of a ChromSpher C18 column (150-mm length × 4.6 mm i.d., 5 μm particle size, Chrompack) connected to a C18 guard column (4-mm length × 3.0 mm i.d., 3.5 μm particle size). The oven temperature was set at 35
• C. The mobile phases consisted of 25 mM TEA-phosphate buffer (A) and acetonitrile (B). The following gradient elution was programed: 95% A at time 0 min, changed to 30% A at 30 min and held for 5 min. The injection volume was 50 μL. The scan range was 220-340 nm and the chromatogram was monitored at 220 nm and 254 nm for 35 min. Before injection of the next sample the column was allowed to re-equilibrate for 10 min. The UV spectrum of an unknown was compared with the UV spectra of approximately 500 compounds present in the library stored in the Polyview software. Identification of active ingredients was based on the retention time (±2%) and similarity index (>0.995).
Mass spectrometry
GC/MS analysis was performed using an Agilent 6890 N gas chromatograph in combination with an Agilent 7683 injector and an Agilent 5973 inert mass selective detector. A Varian CP-SIL 8 CB low-bleed capillary column (30 m × 0.25 mm i.d., 0.25 μm film thickness) was used connected to a fused silica retention gap (2.5 m × 0.25 mm). The carrier gas was helium at a constant flow of 1.1 mL/min. The temperature program was started at 70
• C, held for 2 min, increased to 310
• C at 8
• C/min and held for 23 min, with a runtime of 55 min. The temperatures of the injection port and the detector were set at 300 and 230
• C, respectively. The transfer line temperature was set at 280
• C. The injection volume was 1 μL using the spotless injection mode. Mass spectra were recorded in the range m/z 40-650. Before and after each injection of a sample, a blank injection of methanol was performed. Identification of an active compound was performed by comparing the retention time (±2%) and full-scan mass spectra to reference standards or by NIST computer library search.
Results
In total, 74 preparations in closed or sealed packaging with different batch numbers and 2 unlabeled preparations were analyzed. For the items whose identified compound(s) did not correspond with the labeled active ingredient(s), a reanalysis was performed on a second aliquot. All results confirmed the initial results, which are summarized in Table I. In tablets, capsules, oral gels and water-based injectables one of the following compounds was identified: methandrostenolone, sildenafil, tamoxifen, quinine, clomiphene, dehydroepiandrosterone (DHEA), anastrazole, clenbuterol, stanozolol, oxandrolone, liothyronine, finasteride and melatonin. Item 9 was claimed to contain methandrostenolone, but quinine was identified. Clenbuterol was found in tablets labeled to contain ephedrine (item 38) and in aqueous solution for i.m. injection (item 39) supposed to contain clenbuterol and yohimbine. Anastrazole was present in tablets (item 44) claimed to contain mesterolone. 4-chlorodehydromethyl-testosterone in tablets (item 47) was found to be substituted by metandrostenolone. Item 73 consisted of non-labeled fragments of film-coated tablets (blue coating with white core) in which finasteride was identified.
With the exception of item 45, all oil-based injectables contained androgenic anabolic steroids (AAS). The following anabolic steroids (esters) were identified: testosterone enanthate (17), testosterone propionate (16), nandrolone decanoate (8), boldenone undecylenate (5), testosterone phenylpropionate (3), testosterone decanoate (3), testosterone (3), testosterone isocaproate (2), nandrolone (2), trenbolone acetate (2), methandrostenolone (1), masteron or drostanolone propionate (3), testosterone cypionate (1), masteron enanthate (1), methenolone enanthate (1), trenbolone enanthate (1) and testosterone isocaproate (1) . The number of oily solutions in which the compound was identified is stated between brackets. In items 11, 16, 21, 42, 43, 52, 53, 54 and 55 the labeled active ingredient(s) were substituted with one other or more anabolic steroids. Items 20, 31, 32, 46, 49, 50, 51 and 64 contained one or more additional active ingredients besides the claimed compound(s).
Discussion
Packaging for legitimate pharmaceutical companies and underground labs cannot be differentiated based on their physical appearance: the manufacturer, trade name, active ingredient(s), amount(s), batch number and expiry date were present. Often, a recommended dosage was stated or a package insert was enclosed. Imprints appeared on tablets, ampoules and glass bottles. These findings were consistent with the conclusions of other studies [1] [2] [3] . Only the absence of a registration number compulsory for drugs marketed in Belgium may be an indication for a trained person (pharmacist) that the product is a counterfeit or was purchased abroad, possibly via the internet.
With the exception of the two unlabeled preparations, only preparations in closed and sealed packaging were included in the study so substitution or cross-contamination by the vendor or user could be excluded. The applied HPLC/PDA method is not specific for anabolic steroids, therefore methanolic sample extracts of tablets, capsules, oral gels and water-based injectables were also analyzed on GC/MS.
Although consistent with information found on internet forums and in the literature [7] [8] [9] [10] [11] , it is remarkable to note that drugs used in traditional medicine to treat diseases such as cancer are circulating in the black market among amateur athletes: anastrozole (Arimidex r ) is an aromatase inhibitor with estrogen-blocking properties used to treat breast cancer in women. Bodybuilders use anastrazole in combination with an anabolic (aromatizing) steroid cycle since it reduces side effects such as gynecomastia, acne and water retention and has the additional advantage of increasing testosterone levels. Finasteride (Propecia r , Proscar r ) is an inhibitor of the 5-alpha-reductase enzyme used for the treatment of androgenetic alopecia (1 mg tablets), prostatic hyperplasia and prostate cancer (5 mg tablets). Tamoxifen citrate (Nolvadex r ) and clomiphene (Clomid r ) belong to a class of drugs known as Selective Estrogen Receptor Modulators. Nolvadex r and Clomid r are marketed for the treatment of breast cancer and male hypogonadism, respectively. They are taken by bodybuilders to prevent gynecomastia and as a "recovery drug". They are supposed to influence post-anabolic steroid cycle recovery since they would help raise testosterone, LH and FSH back to normal. Sildenafil is a selective 5-phosphodiesterase inhibitor with vasodilator properties marketed to be effective for erectile dysfunction. It is taken by bodybuilders to overcome the impotence sometimes caused by testosterone injections. On internet forums, sildenafil is promoted as a performance-enhancing drug taken as a pre-workout vasodilator along with AAS. Yohimbine is a centrally-acting selective alpha-2-antagonist medically used for erectile dysfunction and is promoted among bodybuilders as a lipid-mobilizing agent useful during weight loss. Clenbuterol hydrochloride is a selective β2 adrenergic agonist with decongestant and brochodilator properties used in medicine to treat chronic breathing problems. It is taken by bodybuilders for its fat-burning V. Coopman and J. Cordonnier properties and its supposed anabolic effects. Clenbuterol was found in tablets labeled to contain ephedrine. Liothyronine sodium is a synthetic thyroidal hormone used medically as a substitute for the natural thyroid hormone triiodothyronine for the treatment of fatigue, metabolic disorders, obesity and thyroid insufficiency. Liothyronine sodium is used by bodybuilders to burn off excess body fat without the restriction of protein intake. On bodybuilders' forums it is advised to use it in combination with clenbuterol or AAS to heighten its fat-burning ability. In tablets claimed to contain methandrostenolone, quinine was identified as the active ingredient. Thin-layer chromatography was applied to distinguish the diastereoisomers quinine and quinidine. In traditional medicine quinine is prescribed as a muscle relaxant and to treat malaria. On bodybuilders' forums little information was found regarding its use, although it was mentioned that quinine prevents muscle-cramping. Melatonin is a natural hormone secreted by the pineal gland. It is suggested as a supplement to ease jet lag, hasten sleep and to strengthen the immune system. Anabolic androgenic steroids (AAS) are synthetic derivatives of the male hormone testosterone and can be taken orally, by intramuscular injection or in creams or gels. In medicine AAS are used to treat diseases such as delayed puberty, osteoporosis, endometriosis, weight loss due to illness and some types of impotence, anemia or breast cancer. AAS are taken by bodybuilders for their ability to increase muscle mass and decrease body fat. Methyltestosterone, methandrostenolone, oxandrolone, stanozolol and dehydroepiandrosterone were identified in tablets or capsules. Oil-based injectables containing esterified AAS are popular among bodybuilders since they slow the release of the parent steroid from the site of injection, avoiding the need for daily injection. Out of 40 steroidal oily solutions, the active ingredients of 21 (52.5%) did not match the label: one preparation did not contain an active compound, 20 contained other or more active ingredients. The additional compound(s) were often present in smaller quantities than the claimed compound(s). This may be indicative of contamination of raw materials or contamination occurring during production and/or packaging. Testosterone enanthate, testosterone propionate, nandrolone decanoate and boldenone undecylenate were most commonly found in, respectively, 17, 16, 8 and 5 of a total of 41 analyzed oil-based injectables. One of the oil-based injectables did not contain an AAS. In this item only tocopherol was identified and benzyl alcohol and benzyl benzoate were absent. The co-solvents benzyl alcohol and benzyl benzoate were identified in all oily solutions in which AAS were identified. The applied methods do not allow the detection of trace amounts, therefore liquid chromatography and mass spectrometry methods with the use of deuterated internal standards are more suitable. Despite the reported illegal use of protein-and peptide-based substances and selective androgen receptor modulators in elite and amateur sport, no products labeled as such were present in the preparations seized [5] .
Conclusions
The aim of this study was to identify active ingredient(s) present in pharmaceutical products seized from the black market among bodybuilders. Despite the finding that packaging from counterfeits produced in underground labs cannot be visually distinguished from packaging originating from legitimate pharmaceutical companies, this proved not to be a guarantee that the active ingredient(s) present in the preparations match the information claimed on the labels. Out of 74 analyzed products, 25 (33.8%) contained other or did not only contain the labeled active ingredients. Besides the health issues associated with their use, unexpected side effects can occur when preparations do not contain the claimed active compound(s) or amount(s).
Anabolic androgenic steroids are commonly found on the black market among bodybuilders, predominately esterified in oil-based injectables, but also in tablet or capsule form. Out of 40 steroidal oily solutions, the active ingredients of 21 (52.5%) did not match the label. The additional compounds were often present in smaller quantities, which could be indicative of contamination.
Prescribed drugs used in traditional medicine are often purchased by amateur athletes as counterfeits on the black market. They are mainly taken to alleviate adverse effects associated with the abuse of anabolic steroids.
